Nakano Children's Hospital

Osaka 535-0022

0 studies enrolling now · 1 studies all time

What they study most

Respiratory Syncytial Viruses

Studies at this site

• A Study to Evaluate the Antiviral Activity, Clinical Outcomes, Safety, Tolerability, and Pharmacokinetics of Orally Administered Lumicitabine (JNJ-64041575) Regimens in Hospitalized Infants and Children Aged 28 Days to 36 Months Infected With Respiratory Syncytial Virus — Stopped early